These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The effects of thromboxane antagonism on the transit time of platelets through the spleen. Peters AM; Lane IF; Sinclair M; Irwin JT; McCollum CN Thromb Haemost; 1985 Aug; 54(2):495-7. PubMed ID: 2934858 [TBL] [Abstract][Full Text] [Related]
10. Prolongation of cardiac allograft survival with the PAF antagonist BN-52021 and the thromboxane receptor antagonists L640035 and L636499. Foegh ML; Alijani MR; Helfrich GB; Khirabadi BS; Ramwell PW Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():381-4. PubMed ID: 2936126 [No Abstract] [Full Text] [Related]
11. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia. Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270 [TBL] [Abstract][Full Text] [Related]
12. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts. Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627 [TBL] [Abstract][Full Text] [Related]
13. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107 [TBL] [Abstract][Full Text] [Related]
14. Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate. Schwartz CF; Kilgore KS; Homeister JW; Levy BA; Lucchesi BR; Bolling SF J Surg Res; 1999 Sep; 86(1):24-8. PubMed ID: 10452864 [TBL] [Abstract][Full Text] [Related]
15. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816 [TBL] [Abstract][Full Text] [Related]
16. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035). Chan CC; Nathaniel DJ; Yusko PJ; Hall RA; Ford-Hutchinson AW J Pharmacol Exp Ther; 1984 Apr; 229(1):276-82. PubMed ID: 6423813 [TBL] [Abstract][Full Text] [Related]
18. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275 [TBL] [Abstract][Full Text] [Related]
19. Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats. Kort WJ; Bonta IL; Adolfs MJ; Westbroek DL Prostaglandins Leukot Med; 1982 Jun; 8(6):661-4. PubMed ID: 7051048 [TBL] [Abstract][Full Text] [Related]
20. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts. Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]